Catalyst Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Stocks
CN2
US14888U1016
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.30 EUR | +2.63% |
|
+0.74% | +35.01% |
| 16/07 | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | MT |
| 16/07 | Deals of the day-Mergers and acquisitions | RE |
| Market Cap | 385.5Cr 337.06Cr 311.08Cr 286.55Cr 540.47Cr 37TCr 552.29Cr 3.72TCr 1.46TCr 18TCr 1.45TCr 1.42TCr 63TCr | P/E 2026 * |
16.6x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 385.5Cr 337.06Cr 311.08Cr 286.55Cr 540.47Cr 37TCr 552.29Cr 3.72TCr 1.46TCr 18TCr 1.45TCr 1.42TCr 63TCr | EV / Sales 2026 * |
6.1x | EV / Sales 2027 * | 5.43x |
| Free-Float |
94.43% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +2.63% | ||
| 1 week | +0.74% | ||
| Current month | +0.37% | ||
| 1 month | +2.63% | ||
| 3 months | +24.66% | ||
| 6 months | +39.78% | ||
| Current year | +35.01% |
| 1 week | 26.6 |  | 27.3 |
| 1 month | 26.6 | | 27.4 |
| Current year | 18.96 | | 27.4 |
| 1 year | 16.15 | | 27.4 |
| 3 years | 10.93 | | 27.4 |
| 5 years | 4.12 | | 27.4 |
| 10 years | 0.62 | | 27.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 01/01/2024 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 01/01/2024 |
Brian Elsbernd
CMP | Compliance Officer | 62 | 29/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 15/07/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.63% | +0.74% | - | - | 385.5Cr | |
| -0.33% | +1.83% | +23.03% | -6.22% | 6.88TCr | |
| +0.67% | +0.93% | +37.53% | +198.53% | 5.21TCr | |
| +0.94% | +39.60% | +39.60% | +39.60% | 4.35TCr | |
| +1.12% | +0.35% | -50.35% | -52.35% | 4.12TCr | |
| -1.40% | +3.43% | +60.07% | -26.01% | 3.04TCr | |
| -2.11% | -9.45% | +91.99% | -49.58% | 2.45TCr | |
| +0.51% | +0.46% | +70.08% | +91.96% | 2.34TCr | |
| -5.57% | -0.84% | -0.17% | +174.11% | 1.98TCr | |
| -0.86% | -1.99% | +68.42% | +124.39% | 1.66TCr | |
| Average | -0.44% | -0.81% | +37.80% | +54.94% | 3.56TCr | |
| Weighted average by Cap. | -0.30% | -0.07% | +31.34% | +47.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63Cr 55Cr 51Cr 47Cr 89Cr 6.09TCr 91Cr 609.78Cr 239.51Cr 2.98TCr 237.42Cr 232.19Cr 10TCr | 71Cr 62Cr 57Cr 53Cr 99Cr 6.83TCr 101.63Cr 684.22Cr 268.75Cr 3.34TCr 266.41Cr 260.53Cr 12TCr |
| Net income | 23Cr 20Cr 19Cr 17Cr 32Cr 2.23TCr 33Cr 222.94Cr 88Cr 1.09TCr 87Cr 85Cr 3.75TCr | 28Cr 24Cr 23Cr 21Cr 39Cr 2.68TCr 40Cr 268.94Cr 105.64Cr 1.31TCr 104.72Cr 102.41Cr 4.53TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | €27.30 | +2.63% | 0 |
| 13/26/13 | €26.60 | -1.85% | 0 |
| 10/26/10 | €27.10 | -0.37% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
- CN2 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
